Clinical trials

4

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Assessing Functional Impairments in Patients With Chemotherapy-Induced Peripheral Neuropathy

Chemotherapy-induced peripheral neuropathy (CIPN) is a severe side effect of several anti-cancer agents. Typical symptoms include tingling and hypoesthesia in the fingertips and/or toes, which substantially impair patients' quality of life and independence. Providing effective, evidence-based treatments for CIPN remains a major challenge in clinical practice. In a recent randomized clinical trial, our group demonstrated the effectiveness of electrotherapy in reducing both sensory and motor symptoms, as assessed by the EORTC-QLQ-CIPN20 questionnaire and CIPN grading according to CTCAE. However, these findings were based exclusively on patients' subjective self-reports (EORTC QLQ CIPN 20 and C-30). To more objectively evaluate treatment success, functional assessments that capture impairments in daily activities are needed. In this cross-sectional comparison, we will conduct comprehensive functional assessments and correlate the results with patients' subjective ratings using the EORTC-QLQ-CIPN20, QLQ-C30, and CTCAE v5.0 grading. In addition, data from matched healthy controls will be collected and compared with those of CIPN patients. The findings of this study will contribute to the development of objective measures of functional limitations caused by CIPN and provide a valuable complement to patient-reported outcome obtained through validated questionnaires.

Participants needed: 80
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Paracelsus Medical UniversityUpdated: Jan 2, 2026
Eligibility criteria

Pre-existing clinically manifest peripheral neuropathy prior to start of chemoth...

Status: Recruiting

Bone Outcomes, Obesity, Sunlight, and Trauma in Children

Prospective case-control study of children (3-15 years) after low-energy trauma. We compare serum bone metabolic markers (25OHD, PTH, ALP, calcium, phosphate), BMI/percentile, and dietary calcium intake between fracture and non-fracture presentations. Blood is collected within 7 days (non-fasting; samples on ice for PTH). Primary aim: association of ALP and calcium with fracture status; secondary aims: vitamin D status, BMI percentile, and a composite Bone Risk Score (≥3). Analyses: group comparisons, logistic regression, ROC.

Participants needed: 100
Trial details
Age: 3-15Biological sex: AllType: ObservationalSponsor: Paracelsus Medical UniversityUpdated: Sep 3, 2025Locations: 2
Eligibility criteria

3-15 years; [+2]

chronic renal/liver disease; [+5]

Status: Not yet recruiting

A Prospective Randomised Multi - Center Trial on the Repair of Large Hiatal Hernias: Absorbable Mesh vs. Pledgeted Sutures vs. Sutures Only

A prospective randomised multi - center trial on the repair of large hiatal hernias with sutures versus pledgeted sutures versus absorbable mesh The primary objective of the present trial is to compare the hiatal hernia recurrence rate between three different methods of cruroplasty in large hiatal hernias: hiatal closure with sutures versus pledgeted sutures versus absorbable mesh (Phasix™ST mesh). The duration of the study is not limited and depends on the number of cases planned. After enrollment in the study, patients will be followed - up with standardized questionnaires and gastroscopy at 6 months, 1 year, 3 years and 5 years after surgery.

Participants needed: 165
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Paracelsus Medical UniversityUpdated: Apr 2, 2024
Eligibility criteria

Patients with a large hiatal hernia - admitted for surgery (laparoscopic / robot... [+4]

Lack of patient consent for study participation [+5]

Status: Recruiting

FRAMED Infrainguinal Venous Bypass Versus Conventional Autologous Bypass Trial

The purpose of this clinical trial is to analyze patency after autologous infrainguinal bypass surgery in patients receiving a venous conduit versus a covered venous conduit.

Participants needed: 110
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Paracelsus Medical UniversityUpdated: Nov 21, 2023Locations: 1
Eligibility criteria

Age at least 18 years [+3]

Pregnant or breastfeeding women [+9]